Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

The Metabolomic Status of the Differentiating Myeloid Lineage in MDS with Low and High Bone Marrow Blast Counts

Aikaterini Poulaki, MD, Theodora Katsila, PhD, Ioanna E Stergiou, MD, Stavroula Giannouli, MDPhD, Jose Carlos Gόmez Tamayo, Konstantinos Kambas, PhD, George Patrinos, PhD, George Vassilopoulos, MD PhD, Michael Voulgarelis, MD PhD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-140468

Published: 2020

Journal Articles

Pomalidomide Plus Low Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World 'Powerful' Study

Blood (2020) 136 (Supplement 1): 33–35.

https://doi.org/10.1182/blood-2020-138390

Published: 2020

Journal Articles

Oral Ribavirin with or without the Addition of Immune Globulin for the Treatment of Lower Respiratory Tract Infections Due to Respiratory Syncytial Virus or Parainfluenza in Patients after Allogeneic Stem Cell Transplantation

Maria Stamouli, Ioannis Tsonis, MD, Konstantinos Gkirkas, Christina Economopoulou, Thomas Thomopoulos, MD, Anna Paisiou, MD, Nikolaos Siafakas, Spyridon Pournaras, Anastasia Antoniadou, Aggeliki Karagiannidi, Joseph Meletiadis, Dimitra Kavatha, George Vassilopoulos, MD PhD, Stavros Gigantes, MD, Ioannis Baltadakis, MD, Evgenios Goussetis, Dimitrios Karakasis, MD, Panagiotis Tsirigotis

Blood (2019) 134 (Supplement_1): 4498.

https://doi.org/10.1182/blood-2019-128362

Published: 2019

Journal Articles

Decitabine As First Line Treatment in Acute Myeloid Leukemia of the Elderly: Real-Life Experience from a Single Center

Eleni Bouronikou, Eleni Georgiadi, George Vassilopoulos, MD PhD

Blood (2019) 134 (Supplement_1): 5137.

https://doi.org/10.1182/blood-2019-123028

Published: 2019

Journal Articles

Prognostic Significance of Bone Marrow Cellularity in the Outcome of Patients with Myelodysplastic Syndromes Treated with Azacyitidine: A Retrospective Analysis from the Hellenic MDS Study Group

Elena E. Solomou, MD, Alexandra Kourakli, MD PhD, Anna Vardi, MD PhD, Ioannis Kotsianidis, MD PhD, Panagiotis Zikos, MD, Vassiliki Pappa, MD, Athanasios Galanopoulos, MD PhD, Aikaterini Palla, Athina Vyniou, Charalampos Pontikoglou, MD PhD, Panagiotis T Diamantopoulos, MD PhD, Theodoros Vassilakopoulos, MD, Aikaterini Megalakaki, Eleni Variami, Helen A. Papadaki, MD PhD, George Vassilopoulos, MD PhD, Achilles Anagnostopoulos, Argiris Symeonidis, MD PhD

Blood (2019) 134 (Supplement_1): 5417.

https://doi.org/10.1182/blood-2019-131003

Published: 2019

Journal Articles

Foamy Virus Based Vectors for CAR-T Cell Development

Emmanouil Simantirakis, MSc, Vassilis Atsaves, PhD, Ioannis Tsironis, BSc MSc, Margarita Gkyzi, BSc, Kostas Konstantopoulos, MD PhD, George Vassilopoulos, MD PhD

Blood (2019) 134 (Supplement_1): 4646.

https://doi.org/10.1182/blood-2019-123022

Published: 2019

Journal Articles

Autophagy in Myelodysplastic Syndromes: The Role of HIF-1a/REDD1 Molecular Pathway

Ioanna Stergiou, MD, Konstantinos Kambas, PhD, Stavroula Giannouli, MDPhD, Theodora Katsila, PhD, Aglaia Dimitrakopoulou, MD, Veroniki Vidali, PhD, Evgenia Synolaki, Aristea Papageorgiou, MDPhD, Andrianos Nezos, PhD, George Patrinos, PhD, Paschalis Sideras, PhD, Konstantinos Ritis, MDPhD, George Vassilopoulos, MD PhD, Athanasios Tzioufas, MDPhD, Michael Voulgarelis, MD PhD

Blood (2018) 132 (Supplement 1): 1808.

https://doi.org/10.1182/blood-2018-99-112813

Published: 2018

Journal Articles

Increased Age-Related B-Cells in Patients with Aplastic Anemia

Elena E. Solomou, MD, Eva Plakoula, Argiris Symeonidis, MD PhD, Athanasios Galanopoulos, MD PhD, Athina Vyniou, Giannakoulas Nikolaos, MD, Maria D. Palasopoulou, MD, Evgenia Verigou, George Vassilopoulos, MD PhD, Haralambos Gogos, MD, Antonis Kattamis, Stamatis-Nick Liossis, MD

Blood (2018) 132 (Supplement 1): 5099.

https://doi.org/10.1182/blood-2018-99-115120

Published: 2018

Journal Articles

Characteristics of Long-Term Survival of Patients with MDS Treated with 5-Azacytidine. Results from the Hellenic 5-Azacytidine Registry

Blood (2018) 132 (Supplement 1): 3107.

https://doi.org/10.1182/blood-2018-99-115206

Published: 2018

Journal Articles

Natural Killer Cell Cytotoxicity Is a Predictor of Outcome for Patients with High Risk Myelodysplastic Syndrome and Oligoblastic Acute Myeloid Leukemia Treated with Azacytidine

Panagiotis Tsirigotis, Renata Grigoriou, Violetta Kapsimalli, Kleopatra Dagla, Evi Konsta, Konstantinos Gkirkas, Maria Stamouli, Aggeliki Karagiannidi, George Vassilopoulos, MD PhD, Konstantinos Gkodopoulos, MD, Vassiliki Pappa, MD, Maria Tsirogianni

Blood (2017) 130 (Supplement 1): 2976.

https://doi.org/10.1182/blood.V130.Suppl_1.2976.2976

Published: 2017

Journal Articles

Prognosis of Lower Risk Patients with Myelodysplastic Syndromes without Isolated Del(5q) after Failure of Erythropoiesis-Stimulating Agents. a Multicenter Study By the Hellenic MDS Study Group

Athanasios G. Galanopoulos, MD PhD, Christos K. Kontos, PhD, Argiris Symeonidis, MD PhD, Ioannis Kotsianidis, MD PhD, Alexandra Kourakli, MD, Vassiliki Pappa, MD, Thomas Tsiambalis, Anastasia Pouli, MDPhD, Panayiotis Panayiotidis, MD PhD, Paraskevi Roussou, Stamatis Karakatsanis, Kalliopi Zafeiropoulou, Maria Dimou, Theodoros P. Vassilakopoulos, MD PhD, Anna Vardi, MD PhD, Dimitrios Tsokanas, George Drakos, Eleftheria Hatzimichael, Aikaterini Megalakaki, Panagiotis Repousis, MD, Maria Kotsopoulou, Elena E. Solomou, MD PhD, Georgia Kaiafa, Menelaos Konstantinos Papoutselis, Anastasia Sioni, Nikolaos Charchalakis, PhD, Eleni Bouronikou, George Vassilopoulos, MD PhD, Vasileios Lazaris, Athanasios Galanopoulos, MD PhD, Panagiotis Theodorou Diamantopoulos, MD PhD, Flora Kontopidou, Zoi Topouzoglou, Stamatina Kalyva, Helen A. Papadaki, MD PhD, Apostolos Hatzitolios, Achilles Anagnostopoulos, Nikolaos Anagnostopoulos, Nora-Athina Viniou

Blood (2017) 130 (Supplement 1): 2979.

https://doi.org/10.1182/blood.V130.Suppl_1.2979.2979

Published: 2017

Journal Articles

Patients with Myelodysplastic Syndromes, Other Than Del(5)q Syndrome, Exhibiting Del(5)q Alone or Associated with One Additional Chromosomal Abnormality Have Comparable Probability and Duration of Response to Lenalidomide, with Patients Classified As Del(5)q Syndrome

Argiris Symeonidis, MD PhD, Alexandra Kourakli, MD, Ioannis Kotsianidis, MD PhD, Panagiotis Zikos, Eleftheria Hatzimichael, Theodoros Vassilakopoulos, MDPhD, Aikaterini Palla, Vassiliki Pappa, MD, Evgenia Verigou, Zafeirios Kartasis, MD, Eirini Katodritou, Maria Pagoni, Theodora Assimakopoulou, Charalampos Pontikoglou, MD PhD, Maria Dimou, George Xanthopoulidis, Maria K. Angelopoulou, MD, Maria Kotsopoulou, Dimitra Liapi, Despina Mparmparousi, Evridiki Michali, Anna Kioumi, Nora-Athina Viniou, Achilles Anagnostopoulos, Vassiliki Labropoulou, Maria Dalekou, Michael Voulgarelis, MD PhD, Efthymia Vlachaki, Anna Christoforidou, Ioannis Adamopoulos, MD, Akrivi Kostourou, Petros Laos, Evangelos Terpos, MD PhD, Eleni Kapsali, George Vassilopoulos, MD PhD, Helen A. Papadaki, MD PhD, Panayiotis Panayiotidis, MD PhD, Athanasios Galanopoulos, MD PhD

Blood (2017) 130 (Supplement 1): 1696.

https://doi.org/10.1182/blood.V130.Suppl_1.1696.1696

Published: 2017

Journal Articles

The Clinical Significance of Chromosome 17 Abnormalities in Myelodysplastic Syndrome Treated with 5-Azacytidine. Results from the Hellenic 5-Azacytidine Registry

Blood (2017) 130 (Supplement 1): 1701.

https://doi.org/10.1182/blood.V130.Suppl_1.1701.1701

Published: 2017

Journal Articles

Validation of the Revised International Prognostic Scoring System in 2582 Patients with Myelodysplastic Syndrome: A Multicenter Study By the Hellenic MDS Study Group

Athanasios Galanopoulos, MD PhD, Christos K. Kontos, Nora-Athina Viniou, MD PhD, Ioannis Kotsianidis, MD PhD, Vassiliki Pappa, MD PhD, Aleka Kourakli, MD PhD, Anastasia Pouli, Panayiotis Panayiotidis, MD PhD, Paraskevi Roussou, MD PhD, Kalliopi Zafeiropoulou, Stamatis Karakatsanis, Maria Dimou, Anna Vardi, Theodoros Vassilakopoulos, MD PhD, Dimitris Tsokanas, Eleftheria Hatzimichael, MD PhD, Aikaterini Megalakaki, MD, Georgia D Kaiafa, MD PhD, Menelaos Konstantinos Papoutselis, Anastasia Sioni, Nikolaos Charchalakis, MD PhD, Eleni Bouronikou, MD PhD, George Vassilopoulos, MD PhD, Vasilios Lazaris, Maria Spiliotopoulou, Panagiotis Theodorou Diamantopoulos, Flora Kontopidou, MD PhD, Zoi Topouzoglou, Stamatina Kalyva, Helen A. Papadaki, MD PhD, Apostolos I Hatzitolios, Professor of Internal MDcine, Achilles Anagnostopoulos, MD, Evangelos Briasoulis, MD PhD, Nikolaos I. Anagnostopoulos, MD, Argiris S. Symeonidis, MD PhD

Blood (2016) 128 (22): 2004.

https://doi.org/10.1182/blood.V128.22.2004.2004

Published: 2016

Journal Articles

ETV6/RUNX1-Postitive Childhood Acute Lymphoblastic Leukemia (ALL): Do Additional Aberrations Influence Treatment Response and Outcome?

Maria Ampatzidou, Stephanos I. Papadhimitriou, MD PhD, George Paterakis, MD PhD, Loizos Petrikkos, MD, Dimitrios Pavlidis, Konstantinos Tsitsikas, Vassilios Papadakis, MD PhD, George Vassilopoulos, MD PhD, Sophia Polychronopoulou, MD PhD

Blood (2014) 124 (21): 2403.

https://doi.org/10.1182/blood.V124.21.2403.2403

Published: 2014

Journal Articles

Rituximab Is Highly Effective In The Treatment Of Patients With Autoimmune Blood Cytopenias, Particularly When It Is Followed By a Post-Induction Consolidation / Maintenance Phase

Argiris Symeonidis, MD, PhD, Nikolaos Giannakoulas, Eleni Kapsali, Anna Christoforidou, Zoe Topouzoglou, Polyxeni Lampropoulou, MD, Evangelia Tzouvara, Nikolaos Anagnostopoulos, MD, Dimitris Margaritis, George Vassilopoulos, MD, PhD, Evangelos Briasoulis, Alexandra Kouraklis

Blood (2013) 122 (21): 3539.

https://doi.org/10.1182/blood.V122.21.3539.3539

Published: 2013

Journal Articles

Fast Detection Of MYD88 -L265P Mutation By PCR-RFLP In Chronic Lymphoproliferative Disorders

Nikoletta Argentou, George Vassilopoulos, MD, PhD, Maria Ioannou, Anastasios Germenis, Matthaios Speletas

Blood (2013) 122 (21): 5076.

https://doi.org/10.1182/blood.V122.21.5076.5076

Published: 2013

Journal Articles

Severe Sickle Cell Disease Is Characterized by Low ADAMTS13/VWF: Ag Ratio

Despoina Adamidou, Erasmia Rouka, Despoina Kyriakou, Stamatia Theodoridou, E Vetsiou, George Vassilopoulos, MD, PhD, Efthimia Vlachaki, MD, PhD

Blood (2012) 120 (21): 3235.

https://doi.org/10.1182/blood.V120.21.3235.3235

Published: 2012

Journal Articles

Isolation and Functional Characterization of a Novel “Oxidative State – low” Leukemic Population with Stem Cell Properties and Potential Resistance to Chemotherapy In Acute Myeloid Leukemia.

Eleni D. Lagadinou, MD, PhD, Dimitra Kokkinou, Elena Siapati, PhD, George Vassilopoulos, MD, PhD, Craig T. Jordan, PhD, Alexandros Spyridonidis, MD, PhD

Blood (2010) 116 (21): 1580.

https://doi.org/10.1182/blood.V116.21.1580.1580

Published: 2010

Journal Articles

AML Survival and In Vivo Progression Is Dependent On β-Catenin Signaling.

Elena K Siapati, PhD, Magda Papadaki, MSc, Zoi Kozaou, Erasmia Rouka, Evridiki Michali, MD, Dimitrios Gogos, Ioanna Savvidou, Despoina S Kyriakou, MD, PhD, Nikolaos.I. Anagnostopoulos, George Vassilopoulos, MD, PhD

Blood (2009) 114 (22): 2398.

https://doi.org/10.1182/blood.V114.22.2398.2398

Published: 2009

NARROW

The Metabolomic Status of the Differentiating Myeloid Lineage in MDS with Low and High Bone Marrow Blast Counts

Pomalidomide Plus Low Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World 'Powerful' Study

Oral Ribavirin with or without the Addition of Immune Globulin for the Treatment of Lower Respiratory Tract Infections Due to Respiratory Syncytial Virus or Parainfluenza in Patients after Allogeneic Stem Cell Transplantation

Decitabine As First Line Treatment in Acute Myeloid Leukemia of the Elderly: Real-Life Experience from a Single Center

Prognostic Significance of Bone Marrow Cellularity in the Outcome of Patients with Myelodysplastic Syndromes Treated with Azacyitidine: A Retrospective Analysis from the Hellenic MDS Study Group

Foamy Virus Based Vectors for CAR-T Cell Development

Autophagy in Myelodysplastic Syndromes: The Role of HIF-1a/REDD1 Molecular Pathway

Increased Age-Related B-Cells in Patients with Aplastic Anemia

Characteristics of Long-Term Survival of Patients with MDS Treated with 5-Azacytidine. Results from the Hellenic 5-Azacytidine Registry

Natural Killer Cell Cytotoxicity Is a Predictor of Outcome for Patients with High Risk Myelodysplastic Syndrome and Oligoblastic Acute Myeloid Leukemia Treated with Azacytidine

Prognosis of Lower Risk Patients with Myelodysplastic Syndromes without Isolated Del(5q) after Failure of Erythropoiesis-Stimulating Agents. a Multicenter Study By the Hellenic MDS Study Group

Patients with Myelodysplastic Syndromes, Other Than Del(5)q Syndrome, Exhibiting Del(5)q Alone or Associated with One Additional Chromosomal Abnormality Have Comparable Probability and Duration of Response to Lenalidomide, with Patients Classified As Del(5)q Syndrome

The Clinical Significance of Chromosome 17 Abnormalities in Myelodysplastic Syndrome Treated with 5-Azacytidine. Results from the Hellenic 5-Azacytidine Registry

Validation of the Revised International Prognostic Scoring System in 2582 Patients with Myelodysplastic Syndrome: A Multicenter Study By the Hellenic MDS Study Group

ETV6/RUNX1-Postitive Childhood Acute Lymphoblastic Leukemia (ALL): Do Additional Aberrations Influence Treatment Response and Outcome?

Rituximab Is Highly Effective In The Treatment Of Patients With Autoimmune Blood Cytopenias, Particularly When It Is Followed By a Post-Induction Consolidation / Maintenance Phase

Fast Detection Of MYD88 -L265P Mutation By PCR-RFLP In Chronic Lymphoproliferative Disorders

Severe Sickle Cell Disease Is Characterized by Low ADAMTS13/VWF: Ag Ratio

Isolation and Functional Characterization of a Novel “Oxidative State – low” Leukemic Population with Stem Cell Properties and Potential Resistance to Chemotherapy In Acute Myeloid Leukemia.

AML Survival and In Vivo Progression Is Dependent On β-Catenin Signaling.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only